SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ecoscience (ECSC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: WWS who wrote (3)8/4/1996 9:28:00 PM
From: Steve Harmon   of 145
 
Bill, just imagine what Monsanto would pay to purchase ECSC. A minimum of $5 a share. Remember Monsanto just paid big money for Ecogen and Calgene technology. ECSC will not sell technology because they will use their products for profitability not just surviving. Biggest shareholder recently increased their position in company from 8 to 15 percent. If Wall Street gets a whiff of upcoming profits stock should reach levels attained two years ago when they were covered by Oppenheimer & Co. Stock just needs a little sponsorship and it will take off. Recent correction in stock provides a great bargain.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News